Sona Group reinforces its position in Ukraine’s hospital market.
In 2025, Sona-Pharm, part of Sona Group, ranked:
#3 supplier to private clinics in Ukraine
#2 among the Top 10 INNs by procurement volume
These results reflect the scale of our operations, the consistency of our execution, and the strength of our partnerships across the healthcare system. The figures are based on data from PharmXplorer / Farmstandart, the market research analytical system developed by Proxima Research.
Our analysis of hospital procurement and drug deliveries in Ukraine also points to several important market developments in 2025:
- Centralized procurement reached UAH 15.7 billion, covering more than 97% of planned volumes
- Total drug consumption increased by 13%, indicating sustained market demand
- Nearly 35,000 tenders were accepted, reflecting continued procurement activity and system engagement
As Vitalii Gordiienko, Regional Director of Sona-Pharm, part of Sona Group notes:
“These figures highlight a clear trend: Ukraine’s hospital market continues to demand reliable supply, strong execution, and partners capable of operating effectively in a complex healthcare environment. This is where disciplined delivery and long-term partnership models make a measurable difference.”
At Sona Group, we remain focused on strengthening market access and ensuring consistent delivery across the healthcare system - with the clear goal of supporting providers and improving access to treatment for patients.
